Spectroscopy and Spectral Analysis, Volume. 36, Issue 5, 1488(2016)
Orthogonal Experiment for Optimization of the Sample Pretreatment Conditions for the Serum Cholesterol and Markers Determination by GC-MS
[1] [1] Gylling H. International Journal of Clinical Practice, 2004, 58(9): 859.
[2] [2] Mia Hedman, Miettinen Tatu A, Gylling Helena, et al. The Journal of Pediatrics, 2006, 148(2): 241.
[3] [3] Miettinena Tatu A, Gylling Helena, Viikari Jorma, et al. Atherosclerosis, 2008, 200(1): 177.
[4] [4] Silbernagel Guenther, Fauler Guenter, Renner Wilfried, et al. Journal of Lipid Research, 2009, 50(2): 334.
[5] [5] Miettinen T A, Gylling H, Nissinen M J. Nutrition, Metabolism and Cardiovascular Diseases, 2011, 21(10): 765.
[6] [6] Edwards Selvin H, Kimberly Mary M, Pyatt Susan D, et al. Clinical Chemistry, 2011, 57(4): 614.
[7] [7] Zhou W, Li H, Dong J, et al. Clinical Chemistry and Laboratory Medicine, 2011, 49(4): 669.
[8] [8] Hojo Kazuhiro, Hakamata Hideki, Takahashi A, et al. Journal of Chromatography B, 2011, 879(11-12): 751.
[9] [9] Briche Céline S J Wolff, Carter David, Webb Kenneth S. Rapid Communications in Mass Spectrometry, 2002, 16(9): 848.
[12] [12] Amaral C, Gallardo E, Rodrigues R, et al. Journal of Chromatography B, 2010, 878(23): 2130.
Get Citation
Copy Citation Text
ZHANG Yu, WANG Dong-fang, CAO Bing, LUO Shi-heng, LIU Ya-qiong, HUANG Ning-hua, YAN Lai-lai, WANG Jing-yu. Orthogonal Experiment for Optimization of the Sample Pretreatment Conditions for the Serum Cholesterol and Markers Determination by GC-MS[J]. Spectroscopy and Spectral Analysis, 2016, 36(5): 1488
Received: Mar. 12, 2015
Accepted: --
Published Online: Dec. 20, 2016
The Author Email: